triumph-1 trial retatrutide Results: for Obesity Lilly's triple agonist, retatrutide, delivered

Who Is Well-Suited Patients in the early-to-mid phase of GLP-1 treatment represent the strongest candidates for a concurrent photobiomodulation protocol specifically those who want to proactively support their skins collagen biology and lean mass during the loss process, and those with mild-to-moderate laxity (skin that feels loose or less firm but does not involve significant excess skin surface area)

Who should not use retatrutide

Not every patient needs this treatment approach Noom-affiliated prescribers, at their discretion on a patients need, can also prescribe branded GLP-1 medications like Zepbound, oral medications like metformin, and alternate GLP-1 medications like liraglutide but for those who do it could mean all the difference

Syringe Units = Volume to Draw (mL) 100 = 1.0 mL 100 = 100 units NAD+ Dosing Profile (100 mg/mL Concentration) 50 mg Dose: Draw 50 units (0.5 mL)

High Triglycerides and GLP-1 Medications: What to Know GLP-1 medications consistently lower triglycerides in clinical trials, often substantially, making them a particularly relevant treatment option for patients with elevated triglycerides alongside obesity or metabolic syndrome

Yue X, Liang J, Gu F, Du D, Chen F